Results 251 to 260 of about 41,565 (267)

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

JAMA - Journal of the American Medical Association, 2012
Afsaneh Shirani, Yinshan Zhao, Mohammad Ehsanul Karim   +2 more
exaly  

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

Lancet, The, 1998
George C Ebers
exaly  

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

New England Journal of Medicine, 2008
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold   +2 more
exaly  

Relapsing-Remitting Multiple Sclerosis

2017
Kathleen L. Fuchs, John DeLuca
openaire   +1 more source

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis

Multiple Sclerosis Journal, 2008
Arthur F Kramer
exaly  

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Lancet, The, 2004
Valerie Durkalski, William R Tyor, John Corboy   +2 more
exaly  

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Therapeutic Advances in Neurological Disorders, 2018
Giancarlo Comi, Stuart Cook, Kottil Rammohan   +2 more
exaly  

Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

Autoimmunity Reviews, 2019
Yang Hu, Hao Nie, Hai-Han Yu
exaly  

Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis

Multiple Sclerosis Journal, 2005
D R Altmann, W Rashid, C M Griffin
exaly  

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Per Soelberg Sørensen, Thor Petersen, Egon Stenager   +2 more
exaly